What is the treatment for bacterial conjunctivitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Bacterial Conjunctivitis

For bacterial conjunctivitis, topical antibiotics such as gatifloxacin 0.5% ophthalmic solution should be administered every two hours on day 1, then 2-4 times daily for days 2-7 to effectively treat the infection and allow earlier return to normal activities. 1

Diagnosis and Presentation

Bacterial conjunctivitis typically presents with:

  • Mucopurulent discharge
  • Eyelids matted shut, especially upon waking
  • Lack of itching (distinguishes from allergic conjunctivitis)
  • No history of previous conjunctivitis 2

While no single sign or symptom can definitively differentiate bacterial from viral conjunctivitis, bacterial conjunctivitis is more common in children, while viral and allergic forms are more prevalent in adults 2.

First-Line Treatment

Standard Cases (Non-Severe)

  • Topical fluoroquinolones are effective first-line agents:
    • Gatifloxacin 0.5%: Instill one drop every two hours while awake on day 1, then 2-4 times daily for days 2-7 1
    • Other options include gentamicin, tetracycline, or ofloxacin 3

Special Considerations

  • Neonatal conjunctivitis: Requires systemic antibiotics based on onset:

    • 1-7 days after birth: Treat for gonococcal infection (ceftriaxone)
    • 5-19 days: Treat for chlamydial infection (erythromycin)
    • First week: Common bacterial pathogens (S. aureus, Enterococcus, etc.) 3
  • Gonococcal/chlamydial infections: Require systemic treatment in addition to topical therapy 3, 4

Treatment Duration and Expectations

  • Most uncomplicated cases resolve in 1-2 weeks 4
  • Topical antibiotics decrease duration of symptoms and allow earlier return to school or work 4
  • Children can typically return to school after 24 hours of antibiotic treatment 3

Antibiotic Selection Considerations

Fourth-generation fluoroquinolones (gatifloxacin, moxifloxacin) have better coverage of gram-positive pathogens than earlier generations 5. Moxifloxacin has high potency and favorable pharmacokinetics, allowing for a three-times-daily dosing schedule 6.

Besifloxacin 0.6% is also effective for bacterial conjunctivitis with potency similar to fourth-generation agents 5.

Prevention of Transmission

  • Strict personal hygiene with frequent handwashing
  • Avoid sharing towels, washcloths, and pillows
  • For children with bacterial conjunctivitis, return to school is appropriate after 24 hours of antibiotic treatment 3, 2

When to Refer to Ophthalmology

Immediate referral is necessary for:

  • Neonatal conjunctivitis
  • Severe pain or decreased vision
  • Recent ocular surgery
  • Vesicular rash on eyelids or nose
  • History of rheumatologic disease
  • Immunocompromised patients
  • No improvement after 3 weeks of treatment 3, 2

Potential Pitfalls

  1. Antibiotic resistance: Methicillin-resistant S. aureus (MRSA) has been isolated with increasing frequency. Fourth-generation fluoroquinolones are generally poorly effective against MRSA 5.

  2. Contact lens wear: Patients should be advised not to wear contact lenses during the course of treatment for bacterial conjunctivitis 1.

  3. Superinfection: Prolonged antibiotic use may result in overgrowth of nonsusceptible organisms, including fungi. If superinfection occurs, discontinue use and institute alternative therapy 1.

References

Research

Conjunctivitis: Diagnosis and Management.

American family physician, 2024

Guideline

Pediatric Conjunctivitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.